We have had £40k value of share traded on a market cap of £6million, 27 trades, market will not move much but IQAI have become a much better buy today than Friday, 2 good pieces of news re IB included in RNS and I think we could creep up into 5s/6s over coming weeks.
RE: Korean FDA (KFDA) has cleared StoneChecker Software for marketing in the Republic of Korea20 Jan 2020 07:33
I think it will consolidate SP and push it on abit, it’s made stonechecker more attractive to sell, easier to sell and at a better price, all positive! Interesting Dr Ganeshan has left Feedback to rejoin IQAI.
With stonechecker up for sale and IQAI concentrating on IB in America , also M Schmainda being appointed as a none executive director probably no need for a full time CEO now. David Smith retained as a consultant so still involved in business also holds 2million shares and I think still has options over another 1.5million shares all at 2.6p cost, so he will not be selling them at 3.5-4p! Think people got to look at the big picture and IB and how they have progressed the last 12 months and the markets they are targeting with brain & stroke AI software, 30-50 billion dollar markets combined, now we all need say 1% of that and the targeted sales of 20-30million dollars are achievable and that is per David Smith! 2020 potentially could be very successful for IB/IQAI and as stated , no funding required, founders own 40% of shares, huge American markers, cutting edge technology in AI and I think company will be bought out at a huge premium if it all plays out as expected!
RE: Video just out - Full interview: More from Imaging Biometrics on the AI deal15 Jan 2020 15:51
Agree, he cannot talk about Stonechecker sale, its price sensitive information , its with the bankers who are conducting sale and we will be informed when completed, hopefully quickly and at a good price. Interview focused on IB which is were IQAI concentrating on this year by the look of things,IQAI are in a much better place than this time last year, sp was 1.5p, now 4.3p so on that basis an improvement! All to play for this year!
What big boys? what fear? DS leaving is disappointing but IB performing very well, plenty of cash, no need for a placing. Grant funding & sales for IB, resellers and sellers agreement in place, Trevor Brown and founding member own 40% of shares, sale of stonechecker to be announced over coming weeks, all to play for.
Jersey, no accounts since 31/12/18, have I missed them, trying to see what cash they have, also when did spreadx take a notifiable position, bought in since Xmas, like the quickness of getting gold out of ground! Deciding whether to commit more funds, thanks in advance.
David Smith was not on the board of directors, so no need to RNS his departure, he may have decided not to renew his contract and do something else but is still involved in company as a consultant, better for tax for both parties and has still 5million options to play with!
DS was not on last weeks RNS , MSchimedia (spelling!) was, maybe because they are focusing on IB in the states and stonechecker being sold his role as a full time director not required, still he has plenty of shares and options, I liked DS very much and will look out for were he goes next.
Tech nick, so if £10million, 5million for company to progress IB products/software and £5million returned to shareholders which equates to a 3.5p dividend per share, so if you held 100,000 shares you would receive £3,500 special dividend! That’s sounds rampy as hell lol but just abit of fun!
Small free float, share price could repeat last summer in anticipation of SC sale, could even be a special dividend to shareholders if sold for say £10million, just guessing, could be way out but I think not impossible! Either way this company has excellent prospects going forward into 2020 and sale of SC will only enhance that.
Well a disappointing finish to year from a share price view after the fireworks of summer, hopefully a quick sale of stonechecker in Jan/Feb, that’s how the bankers will get paid, so in their interest to move it on quickly. Company can focus on IB market and move progress of products quickly into market, regarding funding, DS has stayed £1million raised this year, also IB have substantial grant funding and along with stonechecker proceeds cannot see ant further share dilution going forward. Finally as stated before, DS with share options,TB with 30% of company and loan notes and KS with 9million shares the only way they will get maximum value is buy sale of company which I can see with 12-18 months hopefully for a price well north of 4p, all that is left to say is happy new year to IQAI director’s and shareholders!
Make more money,nice avatar! I think once stonechecker sold and hopefully quickly, company can outline vision for future for IB and push ahead again quickly in 2020. Ultimately you have to faith in management because they are alined with retail shareholders and hold plenty, they gain we gain! TB/DS as said big pay off on sale of company which after the sale of stonechecker could make it more attractive to acquire.
Think it has been posted how company are surprised at how share price has fallen away, this is main market listed but behaves like a AIM share! Punters feel that they can get 5/10/15% short term elsewhere .Remember only 140million shares in circulation but only a small amount of shares being traded that are effecting share price and it can rise just as quickly!